[HTML][HTML] The Antimalarial Drug Artesunate Mediates Selective Cytotoxicity by Upregulating HO-1 in Melanoma Cells
F Jochims, R Strohm, C von Montfort, CK Wenzel… - Biomedicines, 2023 - mdpi.com
Despite great efforts to develop new therapeutic strategies to combat melanoma, the
prognosis remains rather poor. Artesunate (ART) is an antimalarial drug displaying anti …
prognosis remains rather poor. Artesunate (ART) is an antimalarial drug displaying anti …
The Antimalarial Drug Artesunate Mediates Selective Cytotoxicity by Upregulating HO-1 in Melanoma Cells.
F Jochims, R Strohm, C von Montfort, CK Wenzel… - Biomedicines, 2023 - europepmc.org
Despite great efforts to develop new therapeutic strategies to combat melanoma, the
prognosis remains rather poor. Artesunate (ART) is an antimalarial drug displaying anti …
prognosis remains rather poor. Artesunate (ART) is an antimalarial drug displaying anti …
The Antimalarial Drug Artesunate Mediates Selective Cytotoxicity by Upregulating HO-1 in Melanoma Cells
F Jochims, R Strohm, C von Montfort… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Despite great efforts to develop new therapeutic strategies to combat melanoma, the
prognosis remains rather poor. Artesunate (ART) is an antimalarial drug displaying anti …
prognosis remains rather poor. Artesunate (ART) is an antimalarial drug displaying anti …
[HTML][HTML] The Antimalarial Drug Artesunate Mediates Selective Cytotoxicity by Upregulating HO-1 in Melanoma Cells
F Jochims, R Strohm, C von Montfort, CK Wenzel… - …, 2023 - ncbi.nlm.nih.gov
Despite great efforts to develop new therapeutic strategies to combat melanoma, the
prognosis remains rather poor. Artesunate (ART) is an antimalarial drug displaying anti …
prognosis remains rather poor. Artesunate (ART) is an antimalarial drug displaying anti …
The Antimalarial Drug Artesunate Mediates Selective Cytotoxicity by Upregulating HO-1 in Melanoma Cells
F Jochims, R Strohm, C von Montfort… - …, 2023 - search.proquest.com
Despite great efforts to develop new therapeutic strategies to combat melanoma, the
prognosis remains rather poor. Artesunate (ART) is an antimalarial drug displaying anti …
prognosis remains rather poor. Artesunate (ART) is an antimalarial drug displaying anti …
The Antimalarial Drug Artesunate Mediates Selective Cytotoxicity by Upregulating HO-1 in Melanoma Cells
F Jochims, R Strohm, C von Montfort, CK Wenzel… - Biomedicines, 2023 - agris.fao.org
Despite great efforts to develop new therapeutic strategies to combat melanoma, the
prognosis remains rather poor. Artesunate (ART) is an antimalarial drug displaying anti …
prognosis remains rather poor. Artesunate (ART) is an antimalarial drug displaying anti …
The Antimalarial Drug Artesunate Mediates Selective Cytotoxicity by Upregulating HO-1 in Melanoma Cells.
F Jochims, R Strohm, C von Montfort, CK Wenzel… - Biomedicines, 2023 - go.gale.com
Despite great efforts to develop new therapeutic strategies to combat melanoma, the
prognosis remains rather poor. Artesunate (ART) is an antimalarial drug displaying anti …
prognosis remains rather poor. Artesunate (ART) is an antimalarial drug displaying anti …
The Antimalarial Drug Artesunate Mediates Selective Cytotoxicity by Upregulating HO-1 in Melanoma Cells.
F Jochims, R Strohm, C von Montfort… - …, 2023 - search.ebscohost.com
Despite great efforts to develop new therapeutic strategies to combat melanoma, the
prognosis remains rather poor. Artesunate (ART) is an antimalarial drug displaying anti …
prognosis remains rather poor. Artesunate (ART) is an antimalarial drug displaying anti …